The analysis does not include the potential impact of COVID-19 on diabetes prevalence and burden. The authors primarily report on diabetes prevalence and burden; however, they also provide mortality estimates in the analysis. The investigators found that North Africa and the Middle East had an age-standardized total diabetes prevalence of 9.3%, and Oceania had the highest regional age-standardized prevalence of 12.3%. Type 2 diabetes (T2D) is the main driver of the global diabetes burden, accounting for nearly all diabetes cases (96%) and disability-adjusted life years (DALYs). Between 2021 and 2050, the global diabetes prevalence is estimated to increase by 59.7%, from 6.1% in 2021 to 9.8% in 2025.
